|
| NB: The information displayed below does not replace the protocol. The latest protocol version should always be consulted before making clinical decisions. |
|
DRN 021 ACTION LADA (LRN NELon)
|
|
Identify and characterise diabetes towards limiting its progression.
|
|
|
Topic
|
|
Diabetes
|
|
Portfolio Eligibility
|
|
Funded by UKCRC partner
|
|
|
ISRCTN
|
|
|
EudraCT
|
|
|
MREC N° |
P/02/240
|
|
UKCRN ID |
2303
|
|
WHO ID
|
|
|
|
|
Study Type |
Observational
|
|
Design Type |
Cohort study
|
|
Disease(s) |
Multiple complications
|
|
Phase |
Experimental Medicine
|
|
|
Current Status
| Open |
| Closure Date | 31/12/2011 |
|
Sample Size
| 10000 |
| Accrual to Date |
 7% |
|
|
|
Geographical Scope
| International Multi-Centre |
|
Lead Country
| England |
|
Open to new sites
| No |
|
|
Main Inclusion Criteria
|
|
People who have been diagnosed with diabetes for less than 5 years and are between the ages of 30 and 69 years of age will be asked if they wish to be involved in the study. They can be on any form of diabetes treatment either diet, oral hypoglycaemic therapy or insulin.
|
|
|
Main Exclusion Criteria
|
|
They should also not be pregnant or have diabetes due to secondary causes.
|
|
|
Chief Investigator(s)
|
| Prof David Leslie |
|
|
Further details, please contact
|
Mr Mohammed Hawa
Institute of Cell and Molecular Science
Centre for Diabetes and Metabolic Medicine (DMM)
4 Newark Street
London
E1 2AT
UNITED KINGDOM
Tel: 0207 882 2365
m.i.hawa@qmul.ac.uk
|
|
|
Funder(s) |
European Commission - Framework V
|
|
Sponsor(s) |
Queen Mary University of London
|
|
|
|